Clinical Trial Update: Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients [Phase 3]

View source ↗

Summary

A Phase 3 long-term study of pregabalin in idiopathic restless legs syndrome has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Restless Legs Syndrome

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Idiopathic Restless Legs Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2012-09-27